Andrea Hagemann, MD, MSCI

Gynecologic Oncology, Surgeon

Andrea Hagemann

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Center for Advanced Medicine

Center for Advanced Medicine

On WashU Medicine Campus
4921 Parkview Place, Saint Louis, MO 63110

Expertise & Training

Video thumbnail for Andrea Hagemann, MD

Watch video on YouTube

Andrea Hagemann, MD

2 mins

Washington University gynecologic oncologist and surgeon Andrea Hagemann, MD, discusses what gynecologic cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Hagemann: https://siteman.wustl.edu/doctor/andrea-hagemann-md/

Learn more about the Gynecologic Oncology Program at Siteman: https://siteman.wustl.edu/treatment/specialized-programs/gynecologic-oncology/

Almost all cervical cancers are caused by the human papillomavirus (HPV). Here's what you need to know about the link between HPV and cervical cancer: https://siteman.wustl.edu/facts-about-hpv-cervical-cancer/

Symptoms of ovarian cancer can be easy to miss. Learn about what signs to look out for: https://siteman.wustl.edu/subtle-signs-of-ovarian-cancer-women-should-look-out-for/

Endometrial cancer is the 4th most common cancer in women in the U.S., but it's highly curable when caught early. Learn more about the risk factors, symptoms and screening: https://siteman.wustl.edu/endometrial-cancer-symptoms/

Clinical Expertise

Primary Academic Title

Professor of Obstetrics and Gynecology, Division of Gynecologic Oncology, WashU Medicine

Board Certification

  • 2016: American Board of Obstetrics and Gynecology, Gynecologic Oncology
  • 2012: American Board of Obstetrics and Gynecology, Gynecologic Oncology

Training

  • 2004 - 2008: Resident, Obstetrics and Gynecology, WashU Medicine, St. Louis, MO
  • 2008 - 2010: Fellow, Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA
  • 2015 - 2017: Mentored Training Program in Dissemination & Implementation Research in Cancer, WashU Medicine, St. Louis, MO
  • 2018 - 2019: City of Hope Intensive Course in Genomic Cancer Risk Assessment, Duarte, CA

Education

  • 2004: MD, WashU Medicine, St. Louis, MO

Research & Selected Publications

Research Interest

The surgical and medical management of gynecologic malignancies, complex pelvic surgery and minimally invasive surgery (laparoscopy and the da Vinci Surgical System). Hereditary cancer risk assessment and weight management for precision cancer treatment and prevention. Research interests include the study of weight management interventions for endometrial cancer treatment and prevention, implementation of cascade genetic testing into oncology practices for hereditary cancer risk, and the equitable implementation of molecular profiling for endometrial cancer. Dr. Hagemann is the current PI of Project 3 of the Endometrial SPORE.

Research Publications

Cost-Effectiveness of Combined Minimally Invasive Hysterectomy and Bariatric Surgery in Women With Morbid Obesity and Endometrial Hyperplasia or Early-Stage Endometrial Cancer
Authors:

Tankou J, Pollack LM, Wilson E, one or more additional authors omitted Hagemann AR

Journal & Year:

J Minim Invasive Gynecol | 2026

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma
Authors:

Hollis RL, Miller A, Lankes HA, one or more additional authors omitted Hagemann AR, one or more additional authors omitted Gershenson DM

Journal & Year:

Clin Cancer Res | 2026

Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities
Authors:

Podder V, Coleman RL, Hagemann AR, one or more additional authors omitted Slomovitz BM

Journal & Year:

Clin Cancer Res | 2026

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026
Authors:

Cheng HH, Giri VN, Goggins M, one or more additional authors omitted Hagemann A, one or more additional authors omitted Dwyer M

Journal & Year:

J Natl Compr Canc Netw | 2026

Multiomic Characterization of Pre- and Post-Neoadjuvant Chemotherapy-Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy Response
Authors:

Valentine MC, Mullen MM, Kotnik EN, one or more additional authors omitted Hagemann AR, one or more additional authors omitted Fuh KC

Journal & Year:

Cancer Res | 2025

Invited Commentary: Opportunistic Salpingectomy: A Call to Implement Science Arms to Prevent Ovarian Cancer
Authors:

Hagemann AR, Mutch DG

Journal & Year:

J Am Coll Surg | 2025

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer
Authors:

Schab A, Compadre A, Drexler R, one or more additional authors omitted Hagemann AR, one or more additional authors omitted Mullen MM

Journal & Year:

J Clin Invest | 2025

Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice
Authors:

Morris DH, Kosmacki A, Tolby L, one or more additional authors omitted Hagemann AR

Journal & Year:

Gynecol Oncol | 2025